Ascentage Pharma Group International Unsponsored ADR Financial Overview
Ascentage Pharma Group International Unsponsored ADR's market cap is currently $3.58B. The company's EPS TTM is $-0.964; its P/E ratio is ―; Ascentage Pharma Group International Unsponsored ADR is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
Ascentage Pharma Group International Unsponsored ADR Earnings and Revenue History
